Agency News

⚡SII Gets DCGI's Nod to Manufacture COVID-19 Vaccine Sputnik V in India

By PTI

According to the four conditions set by the DCGI, the Serum Institute will have to submit a copy of the agreement between it and the Gamaleya Research Institute of Epidemiology and Microbiology for transfer of cell bank and virus stock and submit the copy of agreement for technology transfer with Gamaleya.

Read Full Story
Read All QuickLY